Src family kinase members have a common response to histone deacetylase inhibitors in human colon cancer cells
Authors:
Open Access
- 29 November 2005
- journal article
- carcinogenesis
- Published by Wiley in International Journal of Cancer
- Vol. 118 (3) , 547-554
Abstract
Histone deacetylase inhibitors (HDIs) induce cell cycle arrest, differentiation and/or apoptosis in numerous cancer cell types and have shown promise in clinical trials. These agents are particularly novel, given their ability to selectively influence gene expression. Previously, we demonstrated that the HDIs butyrate and trichostatin A (TSA) directly repress c‐Src proto‐oncogene expression in many cancer cell lines. Activation and/or overexpression of c‐Src have been frequently observed in numerous malignancies, especially of the colon. Therefore, our observation was particularly interesting since butyrate is a naturally abundant component of the large intestine and has been suggested to be a cancer‐preventive agent. However, c‐Src is not the only Src family kinase (SFK) member to be implicated in the development of human cancers, including those of the colon. Therefore, the relative expression levels of known SFKs were examined in a panel of human colon cancer cell lines. We found a surprisingly diverse expression pattern but noted that most cell lines expressed relatively high levels of at least 2 SFKs. When the effects of butyrate and TSA were examined in representative cell lines, the expression of all SFKs was repressed in a dose‐ and time‐dependent manner. Further, detailed examination of Lck, Yes and Lyn demonstrated that this repression had a direct effect on transcription and was independent of new protein synthesis. These results mirror our earlier data obtained with c‐Src and suggest that SFKs are a major target of HDIs and likely account in part for the anticancer effects of these promising new drugs.Keywords
This publication has 46 references indexed in Scilit:
- Histone deacetylase inhibitors regulate p21WAF1 gene expression at the post‐transcriptional level in HepG2 cellsFEBS Letters, 2004
- SRC Proximal and Core Promoter Elements Dictate TAF1 Dependence and Transcriptional Repression by Histone Deacetylase InhibitorsMolecular and Cellular Biology, 2004
- Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylationOncogene, 2003
- Activation of Src kinase in primary colorectal carcinomaCancer, 2002
- Transcriptional Response of a Human Colon Adenocarcinoma Cell Line to Sodium ButyrateBiochemical and Biophysical Research Communications, 2001
- An Alternative, Human SRC Promoter and Its Regulation by Hepatic Nuclear Factor-1αJournal of Biological Chemistry, 2000
- An alternative pathway for expression of p56lck from type I promoter transcripts in colon carcinomaOncogene, 1997
- CELLULAR FUNCTIONS REGULATED BY SRC FAMILY KINASESAnnual Review of Cell and Developmental Biology, 1997
- Augmented expression of LCK message directed from the downstream promoter in human colorectal cancer specimensEuropean Journal of Cancer, 1996
- Nucleotide sequence of an avian sarcoma virus oncogene (src) and proposed amino acid sequence for gene productNature, 1980